Recent studies on G-protein-coupled receptors revealed that they can dimerize. However, the role of each subunit in the activation process remains unclear. The g-amino-n-butyric acid type B (GABA B ) receptor is comprised of two subunits: GB1 and GB2. Both consist of an extracellular domain (ECD) and a heptahelical domain composed of seven transmembrane a-helices, loops and the C-terminus (HD). Whereas GB1 ECD plays a critical role in ligand binding, GB2 is required not only to target GB1 subunit to the cell surface but also for receptor activation. Here, by analysing chimeric GB subunits, we show that only GB2 HD contains the determinants required for G-protein signalling. However, the HD of GB1 improves coupling ef®cacy. Conversely, although GB1 ECD is suf®cient to bind GABA B ligands, the ECD of GB2 increases the agonist af®nity on GB1, and is necessary for agonist activation of the receptor. These data indicate that multiple allosteric interactions between the two subunits are required for wild-type functioning of the GABA B receptor and highlight further the importance of the dimerization process in GPCR activation.
Introduction
G-protein-coupled receptors (GPCRs) recognize various stimuli, including light, odours, pheromones, tastes, ions and a large variety of hormones and neurotransmitters . These proteins, which are encoded by >1% of the mammalian genes, are therefore involved in a large variety of physiological regulations and functions. Several subfamilies of GPCRs have been de®ned based on their proposed general structure and sequence similarity (Kolakowski, 1994; Bockaert and Pin, 1999) . All possess seven a-helices, which contain extraand intracellular loops connecting them, as well as the C-terminal tail. The intracellular loops and C-terminus are involved in the recognition and activation of the heterotrimeric G-proteins (Bourne, 1997) . Helices, loops and C-terminus are referred to herein as the`heptahelical domain' (HD). For a long time, it has been assumed that one molecule of GPCR interacts with one molecule of G-protein. However, recent studies have revealed that these receptors can form dimers, either homodimers or heterodimers (Salahpour et al., 2000) . Therefore, in light of this emergent concept, the role of each subunit in the recognition and activation of the G-protein needs to be identi®ed.
g-amino-n-butyric acid (GABA) is a major neurotransmitter in the mammalian brain that controls neuronal excitability by activating ionotropic GABA A and GABA C receptors and G-protein-coupled GABA B receptors. The latter inhibits adenylyl cyclase and modulates the activity of a variety of ion channels. Two GABA B receptor types have been identi®ed: GABA B 1 (GB1) (Kaupmann et al., 1997b) and GABA B 2 (GB2) (Jones et al., 1998; Kaupmann et al., 1998; White et al., 1998; Kuner et al., 1999) . These proteins share 35% sequence identity and are related to the family 3 GPCRs, which also includes the metabotropic glutamate (mGlu) and calcium-sensing (CaS) receptors. These GPCRs have a large extracellular domain (ECD), which contains the agonist binding site and shares the same protein folding as bacterial periplasmic binding proteins (O'Hara et al., 1993; Galvez et al., 1999; Kunishima et al., 2000) . Another speci®c feature of these family 3 receptors is that they are likely to function as dimers (Romano et al., 1996; Bai et al., 1999; Kunishima et al., 2000) . In contrast to the mGlu and CaS receptors, which form functional homodimers, the GABA B receptor is a heteromer constituted of both GB1 and GB2 proteins . Indeed, the coexpression of both subunits is required for a fully functional GABA B receptor (Jones et al., 1998; Kaupmann et al., 1998; White et al., 1998; Kuner et al., 1999) .
Why are two subunits required for the formation of a functional GABA B receptor? The GB1 subunit binds all known GABA B ligands (Kaupmann et al., 1997b) and is responsible for the ligand recognition by the heteromeric GABA B receptor (Galvez et al., 2000a,b) , whereas the GB2 subunit is necessary for the correct traf®cking of GB1 to the cell surface (Couve et al., 1998; White et al., 1998) . Indeed, the C-terminal tail of the GB2 subunit, by interacting with that of GB1, masks a signal responsible for the retention of GB1 in the endoplasmic reticulum (ER) (Margeta-Mitrovic et al., 2000; Calver et al., 2001; Pagano et al., 2001) . However, even when this ER retention signal is mutated such that the GB1 subunit Allosteric interactions between GB1 and GB2 subunits are required for optimal GABA B receptor function The EMBO Journal Vol. 20 No. 9 pp. 2152±2159, 2001 reaches the cell surface alone, no functional GABA response can be measured despite the correct binding of GABA B ligands (Margeta-Mitrovic et al., 2000; Calver et al., 2001; Pagano et al., 2001) . This indicates that the GB2 subunit is necessary not only for the correct targeting of the GB1 subunit to the cell surface, but also for the correct functioning of the receptor.
The present study revealed new roles for the heterodimerization of the GABA B receptor and explained why the two subunits are required for the formation of a functional GABA B receptor. Here we show that although the ECD of GB1 is suf®cient to bind GABA B ligands (Galvez et al., 1999; Malitschek et al., 1999) , the ECD of GB2 is required for agonist-dependent activation of the receptor. Conversely, although the HD of GB2 contains the molecular determinants required for the recognition and activation of the same heterologous G-proteins as the wild-type heteromer, the HD of GB1 increases the coupling ef®cacy. These data reveal a modular organization of the GABA B receptor in which four functional and specialized domains cooperate.
Results
Individual chimeric GB1/2 or GB2/1 constructs are not functional When the ER retention signal RSRR in the GB1 C-terminal tail is mutated into ASAR, the mutant receptor GB1 ASA can reach the cell surface alone, bind GABA B ligands, but is still not functional (Margeta-Mitrovic et al., 2000; Calver et al., 2001; Pagano et al., 2001) . We therefore speculated that the HD of GB2 was responsible for G-protein coupling, and so generated a chimeric GABA B receptor (called GB1/2) in which the HD of GB1 was replaced by that of GB2 ( Figure 1A ). The converse chimeric receptor (GB2/1 as well as its ER retention mutant GB2/1 ASA ) was also constructed. For all the constructs described, the GB1a variant (Kaupmann et al., 1997b) has been used. As shown in Figure 1A , all constructs were expressed and displayed the expected molecular weight. In addition, due to the presence of either a c-myc or an HA epitope added at their extracellular N-terminus, GB1 ASA , GB2, GB1/2 and GB2/1 ASA were shown to reach the cell surface (Pagano et al., 2001 ; data not shown). Among these, only GB1 ASA and GB1/2 were able to bind the GB1 selective antagonist [ 125 I]CGP64213, allowing us to show that both subunits bind GABA (Table I ). The functionality of these constructs was then tested after their coexpression with the chimeric G-protein Gqi9 (Gaq in which the last nine C-terminal residues are replaced by those of Gai2). This latter G-protein a-subunit has been shown to couple a wide variety of Gi-coupled receptors to PLC (Conklin et al., 1993) , including the wild-type GABA B heteromeric receptor (Franek et al., 1999) . When expressed alone, none of these constructs, not even the GB1/2 chimera, activated PLC upon application of GABA ( Figure 1B ) or baclofen (data not shown). Only a slight increase in the basal level of IP formation could be detected in cells expressing GB1/2, an activity that was inhibited by GABA. These data show that GB1/2, comprising the GABA-binding domain of GB1 and the Galvez et al. (2000a) ].
Values are means T SEM of at least three independent determinations. Cross-talk between GABA B subunits required for function GB2 HD, does not form a functional receptor that can be activated by GABA. Therefore, we examined whether the coexpression of any of these wild-type or chimeric subunits could form a functional receptor.
Coexpression of GB1/2 and GB2/1 leads to a functional GABA B receptor with wild-type properties The possible formation of a functional GABA B receptor after coexpression of GB1/2 and GB2/1 was tested ®rst, since all four modules (GB1 and GB2 ECDs and HDs) of the GABA B heteromer were conserved in that combination. As observed in cells expressing GB1 + GB2, a large GABA-induced IP formation was measured in cells expressing both GB1/2 and GB2/1 (Figure 2A ). Indeed GABA, baclofen ( Figure 2C ) and APPA (data not shown), three GABA B agonists, stimulated IP formation to similar extents and with similar EC 50 values to cells coexpressing the wild-type subunits. Moreover, the agonist-induced response could be inhibited by the GABA B antagonist CGP64213 with a similar potency to wild-type receptor ( Figure 2C , Table I ). Similar data were obtained when GB2/1 ASA was used instead of GB2/1 (data not shown). These data revealed that both GB1/2 and GB2/1 are correctly folded. Moreover, they show that the modules can be swapped between the two subunits without affecting the function of the heteromer.
Heteromeric nature of ECD is required for agonist activation, but not for G-protein coupling
We then examined the possible formation of a functional receptor after coexpression of two subunits such that the wild-type heteromeric nature of the HDs was conserved, but not that of the ECDs ( Figure 2A ). In cells expressing GB2/1 + GB2, GABA did not stimulate IP formation, but a large increase in the basal IP formation was detectable ( Figure 2A) . Surprisingly, the same high basal activity and no agonist-induced response was also observed in cells expressing GB1 and GB1/2, even though both subunits expressed alone or in combination clearly bind GABA B ligands ( Figure 2B and Table I ) and form heterodimers. Indeed, the GB1 subunit could be immunoprecipitated from cells expressing both GB1 and GB1/2 using a GB2 C-terminal antibody (data not shown). The basal activity observed with the combination GB1 + GB1/2 could not be inhibited by the competitive antagonists CGP64213 (data not shown). However, a signi®cant inhibition of basal IP formation was induced by 1 mM GABA (Figure 2A ), an effect antagonized by CGP64213 (data not shown). Taken together, these data revealed that either of these two combinations of GABA B subunits can activate Gqi9, but that the heteromeric nature of the ECDs is required for the activation by GABA.
Coexpression of GB2 and GB1/2 leads to a functional GABA receptor that couples to the same heterologous G-proteins as the wild-type receptor In order to determine whether the heteromeric nature of HDs is important or not for coupling, combinations in which the heteromeric nature of the ECDs, but not that of the HDs, is maintained were tested ( Figure 3 ).
Coexpression of GB2 and GB1/2 leads to a functional GABA B receptor that possesses GB2 HD only ( Figure 3A ). The wild-type GABA B receptor has been reported to couple not only to Gqi9, but also to Gqi5 and Gqo5, two chimeric Gaq proteins in which the ®ve C-terminal residues have been replaced by those of Gai and Gao, respectively (Franek et al., 1999) . However, it does not ef®ciently couple to the promiscuous G-proteins G15 and G16 (Figure 4) , although these two G-proteins were activated by mGlu 8 receptors (data not shown), as previously described (Blahos et al., 2001) . Like the wild-type and the heteromeric GB1/2 + GB2/1 receptors, the coexpression of GB2 and GB1/2 leads to a receptor T. Galvez et al. 2154 that can ef®ciently activate Gqi9, Gqi5 and Gqo5, but not G15 and G16 (Figure 4) .
In contrast, the coexpression of the subunits GB1 and GB2/1 did not lead to a functional receptor ( Figure 3A ) even when the ER retention signal of both subunits was mutated (GB1 ASA + GB2/1 ASA ). Such an absence of coupling was observed whether GABA, APPA or baclofen was used as agonist, and with all the G-proteins tested (Figure 4 ). This absence of coupling is not due to a low level of expression of the receptor at the cell surface. Indeed, a similar amount of speci®c binding of the membrane GB1-speci®c impermeant radioligand [ 125 I]CGP64213 was detected on intact cells expressing GB1 + GB2 or GB1 ASA + GB2/1 ASA ( Figure 3B) . Moreover, the af®nities of CGP64213 determined on cells expressing GB1 + GB2 or GB1 ASA + GB2/1 ASA were similar (Table I) . Taken together, these data indicate that within the heterodimers, the GB2 HD is necessary to allow coupling to G-proteins, and that it possesses the molecular determinants for G-protein recognition and signalling.
GB1 ASA and GB2/1 ASA form a heteromeric complex unable to activate G-proteins The absence of a GABA-induced response in cells coexpressing GB1 ASA and GB2/1 ASA is not due to the inability of these two subunits to form a heteromeric complex. Indeed, we found that material speci®cally labelled with the GB1 photo-af®nity ligand [ 125 I]CGP71872 (Kaupmann et al., 1997b Malitschek et al., 1999) was co-immunoprecipitated with the HA-tagged GB2/1 ASA in cells coexpressing this subunit and GB1 ASA ( Figure 3C ). After separation on acrylamide gels, this immunoprecipitated 125 I-labelled material appears as a single band with the expected molecular weight of the GB1 ASA protein (data not shown). As a control experiment, the coexpression of GB1 and HA-tagged mGlu 5 receptor did not lead to the coimmunoprecipitation of speci®c [ 125 I]CGP71872 labelling with the HA antibody. Moreover, we found that the amount of [ 125 I]CGP71872 speci®c labelling that could be co-immunoprecipitated in cells coexpressing GB1 ASA and HA-GB2/1 ASA represented~70% of that obtained in cells expressing GB1 + HA-GB2 or GB1/2 + HA-GB2/1 Cross-talk between GABA B subunits required for function ( Figure 3C ). Therefore, GB1 ASA and GB2/1 ASA form heteromers like GB1 and GB2, and like GB1/2 and GB2/1.
Although they can interact with each other, can GB1 and GB2/1 cross-talk with each other? It has been reported that the af®nity of GABA B agonists on GB1 was increased in the presence of GB2 . Here we show that the af®nity of GABA measured in intact cells expressing GB1 ASA was increased 5-to 8-fold in the presence of either GB2 or GB2/1 ASA (Table I ). This indicates that the cross-talk between GB1 ASA and GB2 can also be observed between GB1 ASA and GB2/1 ASA . Then, GB1 ASA and GB2/1 ASA cannot activate the heterologous G-proteins even though they are targeted to the cell surface, interact with and`talk' to each other.
Heteromeric receptors with the HD of GB2 only are not as ef®cient as the wild-type receptor in coupling to Gqi9 In order to identify any possible role of the HD of GB1 in the G-protein coupling of the wild-type receptor, the functional coupling of the GB1/2 + GB2 combination was compared further with that of the wild-type combination. The maximal effects obtained with saturating concentration of agonists on cells expressing GB1/2 + GB2 were found to be about half of those obtained with cells expressing the wild-type or GB1/2 + GB2/1 combinations ( Figures 2, 4 and 5) . Moreover, the EC 50 values of agonists were always higher than those measured in cells expressing the wild-type receptor ( Figure 5 ). These differences are not due to a different level of GB1/2 + GB2 at the cell surface. Indeed, a similar amount of [ 125 I]CGP64213 binding was measured in intact cells expressing either GB1 + GB2 or GB1/2 + GB2 ( Figure 3B ). Moreover the amount of [ 125 I]CGP71872-labelled GB1/2 co-immunoprecipitated with GB2 represented 70% of that immunoprecipitated in cells expressing GB1 + GB2 (Figure 3C ), indicating that the amount of heteromers in GB1/2 + GB2-expressing cells is not drastically different from that in GB1 + GB2-expressing cells. Finally, the GB1/2 subunit is in a high agonist af®nity state in the presence of GB2 (Table I) . Taken together, these data reveal that the heteromeric GB1/2 + GB2 receptor is less ef®cient in activating Gqi9 than the wild-type GABA B receptor, suggesting that the presence of the HD of GB1 is necessary for full coupling to G-proteins of the heterodimer.
Discussion
Among all GPCRs, the GABA B receptor is the only one known so far that requires the presence of two subunits, GB1 and GB2, for ef®cient coupling to G-proteins. We and others have recently shown that GB1 binds GABA B ligands, and that GB2 is necessary for GB1 insertion in the plasma membrane. The present study revealed new roles of both subunits for the formation of a fully functional receptor. We show that the HD of GB2 contains the molecular determinants for the recognition and activation of G-proteins. However, for an ef®cient coupling to G-proteins, the GB1 HD is necessary. In addition, we show that both GB1 and GB2 ECDs are required for GABAinduced activation of the receptor.
Functional specialization of GABA B subunits
We recently reported that the GABA binding site located within the ECD of GB1 plays a critical role in the recognition of GABA B ligands not only by the GB1 subunit expressed alone, but also by the heteromeric GABA B receptor (Galvez et al., 2000a,b) . Here we showed that the HD of GB2 can activate the same G-proteins as those activated by the wild-type receptor. In contrast, such coupling could not be measured in combinations of subunits that have the HD of GB1 only, even though the subunits could reach the cell surface (since the ER retention signal was mutated). It seems likely, therefore, that the GB1 HD does not couple to G-proteins, or at least does not activate the G-proteins tested here.
In order to ascertain further the critical role played by the HD of GB2 in the heteromeric wild-type receptor in G-protein activation, it would be of interest to prevent GB2 coupling to G-proteins and determine whether the heteromer is functional or not. We therefore introduced point mutations in the i3 loop of GB2 (and also in GB1 as a control), similar to those that prevent G-protein coupling in mGlu (Francesconi and Duvoisin, 1998) and CaS (Pollak et al., 1993) receptors. However, all mutant subunits (R679W or R679D in GB2 and K791W or I798S in GB1) still form functional receptors when expressed either with the complementary wild-type subunit or in combination (B.Duthey, J.-P. Pin and L.Pre Âzeau, unpublished data) , showing that these mutations do not prevent the G-protein coupling of the GABA B receptor subunits.
Within the family 3 GPCRs, the second and third intracellular loops play a critical role in G-protein recognition (Pin et al., 1994; Gomeza et al., 1996) and activation (Pollak et al., 1993; Francesconi and Duvoisin, 1998; Chang et al., 2000) , respectively. Indeed, the second intracellular loops of GB1 and GB2 share no sequence similarity, in agreement with the difference noticed here for the G-protein coupling properties of GB1 and GB2. This does not mean that the HD of GB1 does not play a role in the signalling of the heteromeric receptor. Indeed, the GB1 subunit can associate with the transcription factors ATF4 and ATFx (Nehring et al., 2000; White et al., 2000) , suggesting that this subunit may be involved in other transduction cascades not necessarily involving G-proteins.
Cooperative interactions between different GABA B functional domains Although the ECD of GB1 clearly binds GABA B ligands, and although the HD of GB2 can couple and activate G-proteins, a chimeric receptor comprising these two domains (GB1/2) did not lead to a functional receptor that can be activated by GABA when expressed alone. However, it did so when coexpressed with either GB2 or the converse chimera GB2/1. This observation highlights further the importance of cooperative interactions between different GABA B functional domains for a correct activation of the HD of GB2 by the agonist-occupied ECD of GB1. In agreement with this proposal, the heterodimer in which the two ECDs have been swapped between the two subunits (GB1/2 + GB2/1) behaves exactly like the wildtype receptor in all aspects studied here, i.e. coupling ef®cacy, G-protein selectivity, agonist and antagonist potencies and cross-talk between the two subunits. Indeed, our data indicate that cooperativity occurred at the level of both the ECDs and the HDs between the two subunits.
Concerning the ECD, we found that among all wild-type and chimeric GABA B subunits expressed either alone or in combination, only the combinations with both types of ECDsÐi.e. one of GB1 and one of GB2Ðcould form a functional receptor activated by GABA. This reveals that even though GB1 ECD binds GABA, GB2 ECD is required for GABA-induced activation of the receptor. This is in agreement with recent data showing that a small deletion in the GB2 ECD is suf®cient to prevent activation of the heteromer (Jones et al., 2000) . Moreover, it was reported that the GB2 subunit increased agonist af®nity on GB1 . Our data show here that this is observed with both GB2 and GB2/1, suggesting that the GB2 ECD is not only required for GABA B receptor activation, but also responsible for the increased agonist af®nity on GB1.
Concerning the HDs, we showed that although heteromeric receptors comprising the GB2 HD only can couple to G-proteins, its coupling ef®cacy is lower than that measured for the wild-type receptor. In addition, the two other combinations of subunits comprising both types of HDs (GB1 ASA + GB1/2 and GB2/1 ASA + GB2), although they cannot be activated by GABA, display a large constitutive activity not seen with GB1 ASA or GB2 expressed alone. Taken together these data show that the HD of GB1 largely increases G-protein coupling ef®cacy when associated with the HD of GB2.
Insights in GABA B receptor activation As already mentioned, the ECD of the two GABA B subunits share structural similarity with those of mGlu and CaS receptors (Kaupmann et al., 1997b; Galvez et al., 1999 Galvez et al., , 2000a , and with some bacterial amino acid binding proteins (PBPs). The resolution of the structure of these PBPs (Quiocho, 1990) and that of the mGlu 1 ECD (Kunishima et al., 2000) revealed that they comprise two lobes separated by a large cleft where the ligand binds. These two lobes close upon agonist binding, a change in conformation that is likely to be critical for the activation of the receptor (Bessis et al., 2000; Galvez et al., 2000a; Kunishima et al., 2000) . However, the binding domain of mGlu receptor dimerizes and a more drastic change in the general conformation of the ECD dimer is observed upon binding of glutamate (Kunishima et al., 2000) . Indeed, this change in conformation is such that the C-terminal tails of the two protomers, which are distant in the absence of ligand, become closer in the presence of agonist. This is observed even though a single binding domain closes. The HD region is linked to the C-terminus of each ECD; it has been proposed, therefore, that the agonist binding favours the interaction of the two HDs leading to the stabilization of their active state. This is in contrast to the previously proposed mechanism of activation of family 3 GPCRs in which a closed form of one ECD would stabilize the activated state of its associated HD . Accordingly, it is possible that a change in conformation of a possible heterodimeric form of the GB1 and GB2 ECDs is indeed responsible for GABA B receptor activation.
The above hypothesis easily explains our ®nding that both GB1 and GB2 ECDs are required for agonist activation of the receptor. Our recent proposal that GABA binds on the GB1 ECD only (Galvez et al., 2000a) is also in agreement with Kunishima's hypothesis, since the closure of a single mGlu 1 ECD is suf®cient to reach the proposed active state of the dimeric ECD (Kunishima et al., 2000) . Coexpression of GB1 with GB1/2, which form a dimeric receptor that cannot be activated by agonists even though both subunits bind GABA, shows that the stabilization of a closed form of the GB1 ECD is not suf®cient to activate the receptor. Moreover, this suggests that the two GB1 ECDs cannot interact with each other in such a way that they activate the receptor. Interestingly, the coexpression of GB1 and GB1/2 as well as the coexpression of GB2/1 and GB2 lead to the formation of constitutively active receptors that contain either GB1 ECDs only, or GB2 ECDs only, but neither could be activated by agonists. According to the above described hypothesis for receptor activation, the constitutive activity observed may result from an incorrect association of the homodimeric ECDs, which therefore does not prevent the two HDs from activating G-proteins. Interestingly, this observation indicates that the heteromeric nature of the ECDs is required not only for the agonist activation but also to maintain the receptor in its inactive state.
In conclusion, the GABA B receptor appears to be a multidomain protein, with complex allosteric cross-talk required for the normal functioning of the receptor. Although the ECD of GB1 appears to be the main determinant for agonist recognition, the GB2 subunit increases agonist af®nities. Moreover, although the HD of GB2 appears to be the main determinant for G-protein recognition and activation, the HD of GB1 increases its coupling ef®cacy. Finally, our data are consistent with the proposal that a general change in conformation within the ECD dimer of family 3 GPCRs is responsible for the stabilization of an active dimeric form of the HDs. Such a proposal highlights further the importance of the dimerization process in GPCR activation.
Materials and methods

Construction of chimeric receptors
The N-terminus c-myc-and HA-tagged GB1a and GB2 coding sequences described previously (Pagano et al., 2001) have been subcloned into the pRK5 expression vector. To construct the GB1/2 and GB2/1 chimeric receptors, a unique Bsu36I restriction site was introduced in the region coding for the tripeptide Pro434±Pro435±Ala436 and Pro405± Pro406±Lys407 located at the C-terminal end of the extracellular sequence of the c-myc-or HA-GB1a and GB2 subunits, respectively. The fragment between the EcoRI site preceding the start codon and the introduced Bsu36I site was swapped between the two plasmids, therefore creating the GB1/2 and GB2/1 chimera-expressing plasmids. The construction of the HA-mGlu5 receptor expression vector has been described previously (Ango et al., 1999) .
Cell culture, immuno¯uorescence and expression in HEK 293 cells Human embryonic kidney (HEK) 293 cells were cultured and transfected by electroporation as described previously (Franek et al., 1999) . After electroporation, the cells were plated on poly-ornithine-coated dishes. Serum, culture media and other solutions used for cell culture were from Life Technologies, SARL (Cergy Pontoise, France). Immuno¯uorescence on intact cells using the c-myc or HA antibodies was performed as described previously (Pagano et al., 2001) .
Ligand binding assay
Ligand binding experiments were performed on intact HEK 293 cells plated in 24-well plates just after electroporation (107 cells per plate). The day after, cells were equilibrated to 4°C, washed three times with ice-cold binding buffer (20 mM Tris±HCl pH 7.4, 118 mM NaCl, 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 4.7 mM KCl and 1.8 mM CaCl 2 ) and incubated in the presence of 0.1 nM [ 125 I]CGP64213 with or without unlabelled ligands at the indicated concentration (200 ml ®nal volume, for 3 h at 4°C). The incubation was terminated by washing three times with ice-cold binding buffer. The cells were then disrupted with 400 ml 0.1 M NaOH and the bound radioactivity was counted. The amount of protein in each well was measured by the Bradford method. Non-speci®c binding was determined in the presence of 1 mM GABA. (Kaupmann et al., 1997a ) and labelled to a speci®c radioactivity of >2000 Ci/mmol (ANAWA AG, Wangen, Switzerland). L-Baclofen was synthesized in the research laboratories of Novartis Pharma in Basel (Froestl et al., 1995) . Displacement curves were ®tted as described previously (Galvez et al., 2000a) .
Western blotting
Forty-eight hours after transfection, the cells were washed twice in ice-cold Tris±Krebs buffer containing proteases inhibitors (Roche Diagnostics, Meylan, France), scrapped and centrifuged to collect membranes. Samples (10 mg) were loaded on a Tricine±SDS gel for electrophoresis and transferred on nitrocellulose membranes (Amersham Pharmacia Biotech, Orsay, France). After incubation in phosphatebuffered saline (PBS)/5% milk, the membranes were incubated with the monoclonal anti-HA antibody (1/3000; Roche Diagnostics) at room temperature for 2 h. After washing, the membranes were incubated overnight at 4°C with the anti-mouse HRP antibody (Roche Diagnostics). Signal was revealed using an ECL chemioluminescent assay (Amersham Pharmacia Biotech, Orsay, France).
Photo-af®nity labelling and co-immunoprecipitations Crude membranes from HEK 293 cells expressing the different combinations of receptors were prepared and labelled with the GB1 ECD speci®c photo-af®nity ligand [ 125 I]CGP71872 as previously described (Kaupmann et al., 1997b) . Brie¯y, 24 h after transfection, the cells were washed, homogenized in cold Tris±Krebs buffer (20 mM Tris±HCl pH 7.4, 118 mM NaCl, 5.6 mM glucose, 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 4.7 mM KCl and 1.8 mM CaCl 2 ), and centrifuged for 20 min at 40 000 g. The pellet was resuspended in Tris±Krebs buffer. Membranes (50 mg protein) were incubated in the dark for 1 h at room temperature with 0.8 nM [ 125 I]CGP71872. Non-speci®c binding was determined in the presence of 1 mM CGP54626A. Binding was stopped by two washes with cold Tris±Krebs buffer before UV cross-linking. For immunoprecipitation, labelled membranes (200 mg) were resuspended in 100 ml buffer [50 mM HEPES pH 7.5, 150 mM NaCl, 1% (w/v) deoxycholate and protease inhibitors] at 4°C and then centrifuged at 100 000 g for 1 h. After a 5-fold dilution in protein buffer [20 mM HEPES pH 7.5, 150 mM NaCl, 0.1% Triton X-100, protease inhibitors (Roche Diagnostics, Meylan, France)], the supernatants were incubated overnight at 4°C with anti-HA monoclonal antibody (clone 12CA5, 1/250; Roche Diagnostics) and protein A±Sepharose. The pellets were washed ®ve times with cold protein buffer 0.1% Triton X-100. The radioactivity associated with the pellet was counted and the labelled immunoprecipitated receptors detected by SDS±PAGE and autoradiography.
Determination of inositol phosphate (IP) accumulation HEK 293 cells were transfected as described above with the receptor constructs in pRK5 (2 mg), Gqi9 expression vector (2 mg) and carrier DNA (pRK6, 4 mg) (Franek et al., 1999) . Determination of IP accumulation was performed 15 h after transfection as described elsewhere (Franek et al., 1999) .
